Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription

Shlomit Halachmi, Emily Marden, Glover Martin, Heather MacKay, Ciro Abbondanza, Myles Brown

Science · 1994 · 644 citations · 32 references

Concepts

TL;DR

The estrogen receptor is a transcription factor that, upon binding estradiol, attaches to DNA and regulates estrogen‑responsive gene expression. The study identified ERAP160, a 160‑kDa protein that binds the estrogen receptor in an estradiol‑dependent manner, with its interaction correlating with transcriptional activation; antiestrogens block this binding, suggesting ERAP160 mediates estradiol‑dependent transcription and may underlie antiestrogen therapeutic effects in breast cancer.

Abstract

The estrogen receptor is a transcription factor which, when bound to estradiol, binds DNA and regulates expression of estrogen-responsive genes. A 160-kilodalton estrogen receptor-associated protein, ERAP160, was identified that exhibits estradiol-dependent binding to the receptor. Mutational analysis of the receptor shows that its ability to activate transcription parallels its ability to bind ERAP160. Antiestrogens are unable to promote ERAP160 binding and can block the estrogen-dependent interaction of the receptor and ERAP160 in a dose-dependent manner. This evidence suggests that ERAP160 may mediate estradiol-dependent transcriptional activation by the estrogen receptor. Furthermore, the ability of antiestrogens to block estrogen receptor-ERAP160 complex formation could account for their therapeutic effects in breast cancer.

References

32